Carol D. Morris

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

Stefan Bielack, Sigbjørn Smeland, Jeremy Whelan et al. · Journal of Clinical Oncology · 2015 · 412 citations · Full text

EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment

Jeremy Whelan, Stefan Bielack, Neyssa Marina et al. · Annals of Oncology · 2014 · 321 citations · Full text

NCCN Guidelines Insights: Bone Cancer, Version 2.2017

J. Sybil Biermann, Warren Chow, Damon R. Reed et al. · Journal of the National Comprehensive Cancer Network · 2017 · 291 citations · Full text

Bone Disease, Medicine, Cancer Management +10

Survival in Patients Operated on for Pathologic Fracture: Implications for End-of-Life Orthopedic Care

Saminathan S. Nathan, John H. Healey, Danilo Mellano et al. · Journal of Clinical Oncology · 2005 · 212 citations · Full text

Addition of pamidronate to chemotherapy for the treatment of osteosarcoma

Paul A. Meyers, John H. Healey, Alexander J. Chou et al. · Cancer · 2010 · 176 citations · Full text